Key Market Indicators
By 2028, Thailand's vaccination coverage for children aged one year is projected to reach 96%, down slightly from the 97% recorded in 2023. This represents an average annual decline of 0.2 percentage points. Despite this minor decrease, the Thai market has remained relatively stable since 2005. In contrast, the nation's vaccine imports are on the rise. By 2028, Thailand is expected to import vaccines worth $166 million, up from $143 million in 2023. This marks an average annual growth rate of 2.2%. Since 1993, the country's demand for vaccines has increased by 4% per year. On the export front, Thailand's vaccine exports are forecasted to reach $14 million by 2028, a rise from $12 million in 2023. This represents a compound annual growth rate (CAGR) of 3%. Since 1994, Thai vaccine supply has grown by 5.5% annually. In 2023, Thailand was ranked 30th globally in vaccine exports, with Portugal slightly ahead at $12 million. Leading the rankings were Belgium, the United Kingdom, and France, occupying the second, third, and fourth spots, respectively.
